| 发明名称 |
BIOMARKERS OF RENAL DISORDERS |
| 摘要 |
<p>The present invention is directed to the use of marker for Akt2 activation in podocytes as a biomarker to predict toxicity of mTOR inhibitors. Another aspect of the invention relates to a method for preventing graft rejection comprising administering a selective mTORC1 or Akt1 inhibitor in a subject in need thereof.</p> |
| 申请公布号 |
WO2013053919(A3) |
申请公布日期 |
2013.06.06 |
| 申请号 |
WO2012EP70330 |
申请日期 |
2012.10.12 |
| 申请人 |
INSERM |
发明人 |
TERZI, FABIOLA;CANAUD, GUILLAUME;BIENAIME, FRANCK |
| 分类号 |
G01N33/68 |
主分类号 |
G01N33/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
